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Abstract
Highly ordered protein aggregates, termed amyloid fibrils, are associated with a broad range of diseases, many
of which are neurodegenerative, for example, Alzheimer's and Parkinson's. The transition from soluble,
functional protein into insoluble amyloid fibril occurs via a complex process involving the initial generation of
highly dynamic early stage aggregates or prefibrillar species. Amyloid probes, for example, thioflavin T and
Congo red, have been used for decades as the gold standard for detecting amyloid fibrils in solution and tissue
sections. However, these well-established dyes do not detect the presence of prefibrillar species formed during
the early stages of protein aggregation. Prefibillar species have been proposed to play a key role in the
cytotoxicity of amyloid fibrils and the pathogenesis of neurodegenerative diseases. Herein, we report a novel
fluorescent dye (bis(triphenylphosphonium) tetraphenylethene (TPE-TPP)) with aggregation-induced
emission characteristics for monitoring the aggregation process of amyloid fibrils. An increase in TPE-TPP
fluorescence intensity is observed only with ordered protein aggregation, such as amyloid fibril formation, and
not with stable molten globules states or amorphously aggregating species. Importantly, TPE-TPP can detect
the presence of prefibrillar species formed early during fibril formation. TPE-TPP exhibits a distinctive
spectral shift in the presence of prefibrillar species, indicating a unique structural feature of these
intermediates. Using fluorescence polarization, which reflects the mobility of the emitting entity, the specific
oligomeric pathways undertaken by various proteins during fibrillation could be discerned. Furthermore, we
demonstrate the broad applicability of TPE-TPP to monitor amyloid fibril aggregation, including under
diverse conditions such as at acidic pH and elevated temperature, or in the presence of amyloid inhibitors.
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ABSTRACT: Highly ordered protein aggregates, termed amyloid fibrils, are associated with a broad range of diseases, many of 
which are neurodegenerative, for example Alzheimer’s and Parkinson’s. The transition from soluble, functional protein into insolu-
ble amyloid fibril occurs via a complex process involving the initial generation of highly dynamic early-stage aggregates or pre-
fibrillar species. Amyloid probes, for example thioflavin T and Congo red, have been used for decades as the gold standard for de-
tecting amyloid fibrils in solution and tissue sections. However, these well-established dyes do not detect the presence of prefibril-
lar species formed during the early stages of protein aggregation. Prefibillar species have been proposed to play a key role in the 
cytotoxicity of amyloid fibrils and the pathogenesis of neurodegenerative diseases. Herein, we report a novel fluorescent dye (TPE-
TPP) with aggregation-induced emission characteristics for monitoring the aggregation process of amyloid fibrils. An increase in 
TPE-TPP fluorescence intensity is observed only with ordered protein aggregation, such as amyloid fibril formation, and not with 
stable molten globules states or amorphously aggregating species. Importantly, TPE-TPP can detect the presence of prefibrillar 
species formed early during fibril formation. TPE-TPP exhibits a distinctive spectral shift in the presence of prefibrillar species, 
indicating a unique structural feature of these intermediates. Using fluorescence polarization, which reflects the mobility of the 
emitting entity, the specific oligomeric pathways undertaken by various proteins during fibrillation could be discerned. Further-
more, we demonstrate the broad applicability of TPE-TPP to monitor amyloid fibril aggregation, including under diverse conditions 
such as at acidic pH and elevated temperature, or in the presence of amyloid inhibitors. 
INTRODUCTION 
Fluorescence-based techniques have been widely used to study 
protein structure due to their ease of application, flexibility 
and non-invasive nature 
1
. In particular, dye-based assays have 
significantly enhanced our understanding of the complex con-
formational transition of soluble ordered/disordered proteins 
and peptides into insoluble β-sheet rich species, commonly 
known as amyloid fibrils. The aggregation of proteins or pep-
tides into amyloid fibrils is a pathological hallmark of more 
than 50 human disorders, including Alzheimer’s, Parkinson’s 
and dialysis-related amyloidosis 
2,3
. In contrast, amyloid fibrils 
with essential biological activities, often termed functional 
amyloid, have been reported 
4
. In general, protein and peptide 
aggregation is not the direct conversion of soluble monomers 
to insoluble fibrils. Instead, multiple processes may be in-
volved including the generation of transient, intermediately 
folded or unfolded states and oligomers (commonly known as 
prefibrillar species) that act as primary nuclei for further fibril 
growth 
5
. These small oligomeric species are considered to be 
the dominant cytotoxic forms of misfolded proteins 
6,7
. How-
ever, in situ and ex situ identification and characterisation of 
early-stage aggregates are difficult because they are generally 
heterogeneous, are present in minute quantities for a limited 
time, and are highly dynamic in nature 
8
. Congo red and thio-
flavin T (ThT) are the most commonly used dyes in the study 
of protein aggregation associated with diseases. The green 
birefringence from Congo red under polarized light and the 
enhanced fluorescence of ThT are indicative of the presence of 
amyloid fibrils. Assays based on Congo red and ThT, howev-
er, are not able to detect the presence of early-stage aggregates 
9-13
. More recently, penta-formylthiophene acetic acid, 9-
(dicyanovinyl)-julolidine, Nile red, BODIPY-oligomer, N-aryl 
amino naphthalene sulfonate and its analogue, and tryptopha-
nol have been used for the identification of prefibrillar species 
of various fibril-forming peptides and proteins 
14-19
, but most 
of these are specific to particular amyloid proteins. Therefore, 
novel probes that have broad applicability to report on the 
presence of prefibrillar species are desirable. 
 
Full insight into the self-assembly of peptides and proteins 
and their role in disease requires both the identification and 
characterisation of early-stage aggregates and other conforma-
tional states adopted by the polypeptide chain along the path-
way to the formation of amyloid fibrils. Although some pro-
gress has been made in this area, a better understanding of the 
nanoscale assembly of amyloid fibrils from normally soluble 
proteins is crucial for combating protein aggregation diseases 
as well as to exploit their potential benefits 
20
. Previously one 
of us (Y.H.) reported that fluorogens with aggregation-induced 
emission (AIE) characteristics, such as BSPOTPE and TPE-
TPP (Figure 1A, top panel) are non-fluorescent in solution but 
become highly fluorescent when they bind to amyloid fibrils 
of insulin and α-synuclein, respectively 
21-23
. Furthermore, a 
competition experiment between ThT (Figure 1A, bottom pan-
el) and TPE-TPP binding to α-synuclein fibrils indicated that 
TPE-TPP binds more efficiently (with a Kd of 4.36 µM) to the 
same site(s) as that of ThT (whose Kd is 8.48 µM) 
21
. As deriv-
atives of tetraphenylethene (TPE), a typical AIE luminogen, 
the emission of these dyes is triggered by the restriction of 
intramolecular motions (RIM) of the phenyl rotors in their 
aggregated form 
24
. Additionally, in their aggregated state the 
highly twisted nature of the molecular structure impedes π-π 
interactions, thereby displaying strong fluorescence 
23,25
. Simi-
larly, RIM of AIE can also be achieved upon binding to larger 
macromolecules such as proteins. Increasing viscosity, de-
creasing temperature and elevated pressure are further ex-
pected to influence RIM by slowing the intramolecular rota-




In the present study, we applied the aforementioned proper-
ties of TPE-TPP to investigate protein assembly and disas-
sembly. We find that, upon interacting with protein molecules, 
emission from TPE-TPP can specifically monitor the process 
of ordered protein aggregation, such as amyloid fibril for-
mation, even under solution conditions of acidic pH and ele-
vated temperature. Compared to ThT, TPE-TPP is markedly 
more sensitive with regards to recognition of aged amyloid 
fibrils, and no self-quenching of fibril-associated fluorescence 
is observed in the presence of excess dye. In contrast, com-
plete loss of ThT fluorescence was observed during extended 
incubation of hen egg white lysozyme (HEWL) and κ-casein 
fibrils. TPE-TPP fluorescence increases upon generation of 
oligomeric assemblies formed during the early-stage of protein 
aggregation, and displays a significant spectral shift upon 
binding to prefibrillar species. In addition, using a microplate-
based in situ TPE-TPP fluorescence assay, we screened three 
different types of potential inhibitors of amyloid fibril for-
mation acting at various stages of aggregation. In comparison 
to the routinely used amyloid probe ThT, TPE-TPP shows 
broader in vitro applicability to investigate ordered protein 
aggregation process.  
EXPERIMENTAL SECTION 
Materials. TPE-TPP was synthesized as described in the liter-
ature 
21
. All other reagents (proteins, amino acids, chemicals, 
solvents, etc.) were purchased from Sigma Life Sciences and 
Sigma-Aldrich unless otherwise specified. Recombinant D76N 
β2m, αB-crystallin and α-synuclein were expressed and puri-
fied as described previously 
27,28
. The determination of protein 
concentration is described in SI.  
Amorphous aggregation. The change in light scattering at 
350 nm was used to monitor amorphous aggregation of α-LA 
and hen egg white lysozyme (HEWL). Assay conditions are 
described in detail in Table S1 and Table S2. Assays were con-
ducted in Nunc 96 well polypropylene microplates, sealed 
with transparency film, incubated at 37 °C and light scattering 
was monitored using a Biotek Synergy 2 microplate reader. 
Amyloid fibril formation. The fibrillar aggregation of pro-
teins was monitored in Greiner Bio-One 384-well microplates 
(Item No.: 784900, small volume, black, flat bottom and non-
binding) using a Biotek Synergy 2 microplate reader. The con-
ditions for fibril formation are described in detail in Tables S1-
3. Transparent sealing film was used to prevent solvent evapo-
ration. ThT fluorescence emission was measured using a 
440/40 nm filter for excitation and a 485/20 nm filter for emis-
sion, while for TPE-TPP fluorescence, the 380/20 and 460/40 
nm filters were used for excitation and emission, respectively, 
under the fibrillation conditions appropriate for each protein. 
Dye concentrations were 20 µM and 5 µM for in situ and ex 
situ assays, respectively. The TPE-TPP fluorescence assay 
potentially may be affected by a high-binding microplate, 
therefore all TPE-TPP and ThT fluorescence assays were per-
formed using the aforementioned non-binding microplate. 
 
Figure 1. Fluorescence response of TPE-TPP to different forms of α-LA.  (A) Structure of TPE-TPP (top panel) and ThT (bottom panel). (B) Time-course 
turbidity at 350 nm of molten globule (black open circle), apo (red triangle) and holo (blue circle) forms of α-LA. (C) In situ TPE-TPP assay of molten 
globule (black open circle), apo (blue circle), holo (red triangle), and amyloid fibril-forming RCM α-LA (black circle). (D) TEM images of the holo form 
of α-LA and RCM α-LA fibrils formed in the presence of TPE-TPP. 20 µM of dye was used for all fluorescence assays. For TPE-TPP, the excitation and 
emission filters were 380/20 and 460/40 nm, respectively. The conditions for formation of the different α-LA aggregates are summarised in Table S1.  
 
Fluorescence polarization. For FP experiments, amyloid fi-
brils were prepared according to the conditions outlined in 
Tables S1-3 using Greiner Bio-One 384-well microplates 
(small volume, black, flat bottom, and non-binding) with 
transparent sealing film. TPE-TPP was added to 20 µM prior 
to incubation of the protein. FP was recorded in situ with a 
CLARIOstar microplate reader (BMG Labtech) using the FP 
mode and a FP filter set of 380/20 nm for excitation and 
485/20 nm for emission. The background fluorescence of 
TPE-TPP in the corresponding buffer solution under the re-
spective protein fibrillation conditions was subtracted, and the 
change in FP values was expressed in milli-polarization units 
(∆mP). 
RESULTS AND DISCUSSION 
TPE-TPP specifically monitors ordered protein aggrega-
tion. To determine whether TPE-TPP can distinguish between 
various types of protein aggregates, we measured the response 
of TPE-TPP against different aggregation pathways undertak-
en by the same protein under various experimental conditions. 
We first chose α-lactalbumin (α-LA) as the model protein 
because it is a well-characterized protein that can form a mol-
ten globule, amorphous aggregates and amyloid fibrils under 
the appropriate solution conditions (as described in Table S1) 
29
. α-LA forms a characteristic molten globule state at pH 2.0, 
and Ca
2+
-free (apo) and Ca
2+
-bound (holo) α-LA form amor-
phous aggregates under reducing conditions. The rapid for-
mation of amorphous aggregates upon reduction of α-LA was 
apparent from the change of the turbidity of the protein solu-
tion with time, as monitored via light scattering at 350 nm 
(Figure 1B). Reduced and carboxymethylated (RCM) α-LA, 
on the other hand, forms ordered amyloid fibrils under physio-
logical conditions in the presence of Mg
2+
 and with agitation 
30
. Figure 1C shows that TPE-TPP was weakly fluorescent in 
the presence of monomeric α-LA prior to incubation. Moreo-
ver, no enhancement of TPE-TPP emission was observed dur-
ing the process of molten globule or amorphous aggregate 
formation. Interestingly, a significant rise in TPE-TPP fluores-
cence (in a sigmoidal manner) occurred during the fibrillar 
aggregation of RCM α-LA, implying that TPE-TPP is sensi-
tive and selective to amyloid fibril formation. The formation 
of amorphous aggregates by holo α-LA, and fibrils by RCM α-
LA in the presence of ThT and TPE-TPP was confirmed by 
transmission electron microscopy (TEM) with negative stain-
ing (Figure 1D).  
    Similar to α-LA, HEWL can form aggregates of different 
morphology as described in Table S2; for example, amyloid 
fibrils at pH 2.0 and amorphous aggregates at pH 12.2 
31,32
. 
Consistent with the response to the various forms of α-LA, 
TPE-TPP remained weakly fluorescent during the entire pro-
cess of amorphous aggregation of HEWL, as monitored by 
light scattering at 350 nm. By contrast, TPE-TPP exhibited 
significant fluorescence enhancement, displaying a typical 
sigmoidal profile during the formation of lysozyme amyloid 
fibrils at pH 2.0 and 55 °C (Figure S1). Under such extreme 
pH and temperature conditions, ThT is unstable 
33,34
. 
    Moreover, we observed that ThT fluorescence intensity 
underwent major fluctuation even after mature fibrils had 
formed (see below). In addition to chemical reduction and the 
exposure to extreme pH conditions, heat can also denature 
proteins and induce aggregate formation. Both ThT and TPE-
TPP fluorescence remained almost unchanged in the presence 
of bovine serum albumin (BSA) before and after heating to 95 
°C, pH 7.4, i.e. conditions that induce the formation of disor-
dered amorphous aggregates of this protein (Figure S2).  
Observing prefibrillar/oligomeric species during protein 
aggregation. As TPE-TPP shows specific binding to amyloid 
fibrils over amorphous aggregates, we next investigated its 
application to follow the kinetics of protein aggregation, spe-
cifically amyloid fibril formation by RCM α-LA (Figure 2). 
RCM α-LA was incubated with TPE-TPP and ThT inde-
 
Figure 2. Comparison of the time-course aggregation profiles of six different amyloid fibril-forming proteins as monitored by ThT and TPE-TPP fluores-
cence. (A-C) In situ and (D-F) ex situ dye-binding fluorescence (normalized) profile of (A) 100 µM RCM α-LA, (B) 50 µM RCM κ-casein, (C) 35 µM 
HEWL at pH 2.0, (D) 10 µM αB-crystallin, (E) 40 µM D76N β2m and (F) 40 µM α-synuclein. TPE-TPP fluorescence intensity data are represented as 
solid circles and ThT fluorescence as open circles. 20 µM of dye was used for the in situ and 5 µM for the ex situ assays. For ThT, the excitation and emis-
sion filters were 440/40 and 485/20 nm, respectively. For TPE-TPP, the excitation and emission filters were 380/20 and 460/40 nm, respectively. Tables S2 
and S3 summarize the amyloid fibril-forming conditions for each protein. 
B. RCM κ-casein
F. α-synuclein
A. RCM α-LA C. HEWL, pH 2.0
D. αB-crystallin E. D76N β2m
 
pendently, and the change in TPE-TPP and ThT fluorescence 
was monitored over time. TPE-TPP fluorescence intensity 
decreased significantly during the first 30 minutes of incuba-
tion and remained constant for the first 5.5 h (Figure 2A). The 
fluorescence emission of TPE-TPP then increased dramatical-
ly reaching a plateau after 8 h of incubation. The commensu-
rate experiment with ThT showed constant weak fluorescence 
for the first 7 h of incubation and then a slow increase such 
that it had not reached a plateau even after 12 h of incubation. 
Thus, there is a notable difference in the fluorescence profiles 
of both dyes in the presence of aggregating RCM α-LA. It 
appears that TPE-TPP fluorescence is more sensitive to the 
early species formed prior to the formation of fibrillar entities 
than those detected by ThT fluorescence.  
    To examine whether this is a general phenomenon, i.e. that 
TPE-TPP can monitor species formed early during protein 
fibrillation, we extended our studies to other amyloid fibril-
forming proteins. Similar to RCM α-LA, TPE-TPP fluores-
cence intensity exhibited an initial decrease during the incuba-
tion period and then rose at an earlier time point than ThT 
during the fibrillation process of RCM κ-casein and HEWL 
(Figure 2B,C). In each of the three cases examined, the dyes 
were mixed with the proteins before aggregation commenced 
(i.e. in situ assay; Figures 2A-C). To rule out the possibility of 
the early increase in TPE-TPP fluorescence being due to a 
change in the rate of aggregation as a result of the interaction 
of AIE molecules, we also conducted studies involving the 
addition of the dyes to aliquots collected at different time 
points during the aggregation process (i.e. ex situ assay). The 
molecular chaperone protein αB-crystallin, D76N β2-
microglobulin (β2m), a naturally occurring amyloidogenic 
variant of β2m (the protein involved in dialysis-related amy-
loidosis), and the synucleinopathies-associated protein α-
synuclein, were used in this work as they all readily form fi-
brils under the conditions tested 
35-37
. Consistent with the in 
situ assays, TPE-TPP showed fluorescence enhancement with 
these proteins at time points earlier than ThT (Figure 2D-F). 
Both the in situ and ex situ assay results clearly indicate that 
TPE-TPP is capable of detecting early stage/prefibrillar aggre-
gating species which are not observed using ThT. 
Spectral shift of TPE-TPP fluorescence with different pro-
tein species. The normalized emission spectrum of TPE-TPP 
exhibited a significant blue and red shift when it was mixed 
with purified prefibrillar and fibrillar α-LA, respectively, 
compared to that in the presence of the monomeric species 
(Figure 3A). The emission spectrum of TPE-TPP exhibited an 
emission maximum at 474 nm when mixed with RCM α-LA 
monomers, which shifted to 460 nm with prefibrillar RCM α-
LA. In contrast, the emission maximum was red-shifted to 484 
nm when mixed with purified RCM α-LA fibrils. The early-
stage species detected at around 6 h by TPE-TPP (Figure 2A) 
was separated and purified from other RCM α-LA forms using 
native agarose gel electrophoresis and an Ultrafree®-DA cen-
trifugal unit, respectively. The Ultrafree®-DA unit utilises 
centrifugal force and a microporous membrane to disperse the 
agarose gel matrix, thereby allowing recovery of the protein. 
The non-fibrillar spherical morphology of the prefibrillar 
RCM α-LA was confirmed by TEM (Figure 3B). A similar 
hypsochromic shift of TPE-TPP fluorescence emission maxi-
mum to ~465 nm was also observed when it was mixed with 
prefibrillar D76N β2m, but no significant change in the emis-
sion maximum occurred when mixed with fibrillar D76N β2m 
compared to the monomeric form of the protein (Figure S3). 
Thus, such spectral shifts in TPE-TPP fluorescence emission 
can be used to differentiate between various protein forms. 
Absence of self-quenching and fibril maturation-induced 
fluorescence quenching. Younan and Viles reported that an 
excess of ThT can cause quenching of fluorescence upon bind-
ing to amyloid β-peptide fibrils 
38
. To test whether TPE-TPP 
has the same behaviour, the dye-to-protein fibril ratio was 
increased, and fluorescence spectra were recorded. The con-
centration of the pre-formed protein fibrils was fixed at 10 µM 
and the concentration of dye (ThT or TPE-TPP) was altered 
from 1 to 40-50 µM. Consistent with the above study, ThT 
fluorescence decreased once the dye-to-protein concentration 
ratio was greater than 1:1 for both HEWL and α-synuclein 
fibrils (Figure 4A and S4). In contrast, the TPE-TPP fluores-
cence intensity increased proportionally with the increase in 
the dye-to-protein fibril ratio, reaching a plateau when the 
molar ratio reached 2:1 dye: fibrillar protein. No self-
quenching of fluorescence occurred even when the dye-to-
protein fibril ratio was greater than 4:1 for both fibrillar spe-
cies. 
In addition to the problems associated with self-quenching, 
we found that ThT only exhibited appreciable fluorescence 
with fibrils of κ-casein, D76N β2m and HEWL that were 
freshly prepared. In order to examine whether this is also a 
limitation of TPE-TPP, the proteins were incubated under 
conditions conducive to fibril formation for 48 h. At the end of 
the incubation, ThT and TPE-TPP fluorescence spectra of an 
aliquot from each protein was measured (before maturation), 
and the remainder of the sample was then incubated at room 
temperature for an additional 7-30 days and measured (after 
 
Figure 4. Fluorescence change at different dye: fibril stoichiometry, and 
upon maturation of fibrils. (A) Change in fluorescence intensity with 
increasing dye-to-protein concentration ratio. Protein: 10 µM mature α-
synuclein fibrils. The data of dye with mature HEWL fibrils are shown in 
Figure S4. TPE-TPP fluorescence shown by solid black circle and line, 
and ThT fluorescence is represented by an open black circle and dashed 
line (B) Fibril maturation-induced quenching of ThT and TPE-TPP fluo-
rescence. Actual TPE-TPP and ThT fluorescence intensity upon binding 
to non-incubated 2-day (hollow bar) and upon ageing (solid black bar) 
protein fibrils, as indicated in the figure. The concentration of the proteins 
and dyes was each 10 µM.  
 
Figure 3. Fluorescence emission spectrum of TPE-TPP upon binding to 
different forms of α-LA. (A) Normalized TPE-TPP fluorescence emis-
sion upon binding to fresh, non-aggregated (black curve), prefibrillar 
(green curve) and fibrillar (magenta curve) species of RCM α-LA. (B) 
TEM image of RCM α-LA prefibrillar species; scale = 100 nm. The 
TPE-TPP fluorescence emission spectrum was measured with excitation 
at 350 nm. 
A. B.
 
maturation). We measured an ~18 fold decrease in ThT fluo-
rescence signal in the case of 30-day aged RCM κ-casein fi-
brils (Figure 4B). An ~7- and 2.4-fold loss of ThT fluores-
cence signal occurred with 7-day and 30-day-old HEWL and 
D76N β2m fibrils, respectively (Figure 4B). On the contrary, 
no notable reduction of TPE-TPP fluorescence was observed 
between the fibrils formed at 48 h and aged fibrils (7-day-old 
HEWL and 30-day-old D76N β2M fibrils). However, a ~2-
fold signal loss was observed in the case of 30-day aged RCM 
κ-casein fibrils. Hence, unlike ThT, TPE-TPP bound more 
efficiently to aged HEWL, D76N β2m and RCM κ-casein 
fibrillar species. 
This self-quenching effect makes it difficult to measure the 
rate of fibril formation accurately using ThT fluorescence. It is 
also noteworthy to speculate that the extended lag phase in the 
kinetic curves could be attributed to quenching of ThT fluo-
rescence during the early phase of fibrillation, i.e. when the 
amyloid fibril content is much lower than the dye concentra-
tion. As a result, this may lead to inaccuracies in the assess-
ment of the lag phase of the reaction when using in situ ThT 
assays. Similar to our observation, other studies have also 




Monitoring the effects of amyloid fibril inhibitors. Using a 
fluorescence-based approach for rapid screening of potential 
therapeutic agents that can act on various stages of the amy-
loid fibril-forming pathway is a challenging task because of 
the limitations of routinely used amyloid probes. Since TPE-
TPP can follow the kinetics and reveal the early-stage pro-
cesses during protein fibrillation, the effect of small molecules 
on amyloid fibril formation was investigated. We examined 
the effects of lysine and arginine, well-described potent inhibi-
tors of protein aggregation 
40-42
, on RCM α-LA fibrillation 
using TPE-TPP and ThT fluorescence assays (Figure 5A,B). 
No significant increase in TPE-TPP fluorescence was ob-
served when RCM α-LA was incubated in the presence of 
lysine or arginine, suggesting complete suppression of the 
fibrillation process (Figure 5A). The inhibitory effect of lysine 
and arginine was confirmed using a ThT-based fluorescence 
assay (Figure 5B). 
Quinacrine, a tricyclic acridine compound, has also been 
extensively studied for its potential treatment of prion diseases 
and has been reported to inhibit amyloid β peptide fibrillation 
43-45
. We investigated the effect of quinacrine on RCM α-LA 
amyloid fibril formation via TPE-TPP fluorescence (Figure 
5C). Whilst quinacrine did not completely inhibit fibril for-
mation by RCM α-LA, it slowed its rate of fibril formation 
and resulted in a change in fibril morphology, as evident by 
TEM (Figure S5A). When incubated in the presence of quina-
crine, RCM α-LA amyloid fibrils (cf Figure 1D) were much 
shorter with more globular and spherical aggregates when 
quinacrine was not present (Figure S5A). In addition, Ponceau 
S, a diazo dye that is regularly used as a reversible stain for the 
detection of proteins in Western blotting 
46
, modulates RCM 
α-LA fibril formation (Figure 5D). When monitored by TPE-
TPP fluorescence, fibril formation by RCM α-LA in the pres-
ence of Ponceau S had an extended lag phase by about 1.5 h 
compared to when Ponceau S was not present. By prolonging 
the lag phase, the diazo dye acts on the early stage of the pro-
tein’s aggregation, most likely by altering the fibrillation 
pathway resulting in the formation of unstable fibrillar struc-
tures, as observed by TEM (Figure S5B). 
The formation of amyloid fibrils can be prevented in a 
number of ways: by stabilizing the native structure of the pre-
cursor protein or peptide, by inhibiting or altering oligomeri-
zation during the early stage of fibrillation and by modulating 
or suppressing fibril elongation. Identifying distinct inhibitors 
for each of these cases can be a difficult process. The TPE-
TPP fluorescence profiles of RCM α-LA in the presence of 
arginine and lysine suggest that both positively charged amino 
acids stabilised monomeric RCM α-LA, preventing it from 
further aggregation. Ponceau S, a diazo compound, modulated 
the prefibrillar RCM α-LA form leading to the formation of 
unstable fibrillar species, thereby altering the normal RCM α-
LA fibrillation pathway as indicated by the extended lag-
phase. Quinacrine appears to attenuate the rate of RCM α-LA 
amyloid formation, producing shorter fibrillar structures. 
Thus, by monitoring the TPE-TPP fluorescence associated 
with fibril formation, we are able to draw conclusions on the 
possible inhibitory mechanism of different fibril inhibitors. 
Fluorescence polarization for monitoring the oligomeric 
pathway during protein assembly. In addition to measuring 
the change in fluorescence intensity during amyloid fibril for-
mation, we recorded the change in fluorescence polarization 
(FP) of TPE-TPP. FP reflects the mobility of the emitting spe-
cies such that when the fluorescent molecule binds to a small 
target it freely rotates and has small FP values. However, 
when the fluorescent molecule binds to a large molecule, its 
rotation/mobility slows and its FP value increases. The altera-
tion in the FP value is therefore proportional to the relative 
mass of the object to which it binds 
1,47-49
. The change in FP of 
TPE-TPP during the fibrillation of RCM α-LA, RCM κ-casein 
and insulin was therefore measured to examine whether it 
could be used to monitor amyloid fibril formation by these 
proteins. 
 
Figure 5. Screening and evaluation of potential inhibitors for amyloid 
fibril formation as monitored by TPE-TPP fluorescence. (A) TPE-TPP 
fluorescence intensity of 125 µM RCM α-LA in the absence (black 
circle) and presence of 10 mM lysine (blue circle) or 10 mM arginine 
(red circle). (B) ThT fluorescence intensity of 125 µM RCM α-LA in the 
abs nce (open black diamond) and presence of 10 mM lysine (open b e 
diamond) or 10 mM arginine (open red circle). Normalized TPE-TPP 
fluorescence intensity of (C) 125 µM RCM α-LA in the absence (solid 
circle) and presence of 10 µM Quinacrine (open circle), and (D) 125 µM 
RCM α-LA in the absence (solid circle) an  pres nce of 2.6 µM Pon-
ceau S (open circle).  
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    RCM α-LA (monomeric mass 14.7 kDa) follows classical 
nucleation-dependent polymerization as apparent from its 
sigmoidal kinetic fluorescence curve 
30
. Starting from mono-
mers, soluble oligomers with increasing mass were formed 
after 2 h of incubation, as reflected by the steep increase of the 
FP. Afterwards, rigid insoluble fibrils were formed with FP 
reaching a maximum value and staying constant over the next 
8 h (Figure 6A). On the other hand, RCM κ-casein (monomer-
ic mass ~19 kDa) forms amyloid fibrils via a different mecha-
nism with the absence of a significant lag phase. In solution at 
25°C, RCM κ-casein occurs as a spherical particle with a 
weight-average molecular mass of ~1180 kDa 
50
. Consistent 
with the difference in molecular mass, the FP of RCM κ-
casein prior to incubation was higher than that of RCM α-LA 
(Figure 6B). At 37 °C and neutral pH, RCM κ-casein reassem-
bles into fibrillar structures 
50-52
. Amyloid fibril formation by 
RCM κ-casein involves the dissociation of its spherical, oli-
gomeric form into a monomeric amyloidogenic precursor, 
which then undergoes rapid aggregation to form a nucleus 
from which rigid, rod-like amyloid fibrils develop 
51,52
. Bovine 
insulin (monomeric mass 5.8 kDa) forms amyloid fibrils at 
acidic pH (pH 2.0) and elevated temperature (60 °C). Insulin 
exists as a dimer at acidic pH, which rapidly dissociates to 
monomer at higher temperature followed by a conformational 
change. The partially unfolded monomers associate with each 
other to form oligomeric intermediates including dimers, te-
tramers and hexamers 
53
. Hexamers have been reported to be a 
critical prefibrillar intermediate in the formation of mature 
amyloid fibrils 
54
. The progression from monomer to dimer, 
tetramer, hexamer and then to insulin amyloid fibril is ob-
served by the step-wise increase, each of around similar mag-
nitude in the FP of TPE-TPP (Figure 6C). Thus, TPE-TPP-
based FP measurements can map the oligomeric assemblies, 
whilst monitoring the fibrillar assembly, of a variety of amy-
loid fibril-forming protein in situ. Moreover, because FP is 
less dependent on the dye concentration, its signal remained 
constant after reaching the plateau, whereas a decrease in fluo-
rescence intensity is often observed after the formation of in-
soluble fibrils (cf Figure 2).  
Mechanism of TPE-TPP binding to amyloid fibrils. TPE-
TPP is non-fluorescent in buffer solution owing to the aggre-
gation-induced emission property of its TPE core as the fluor-
ophore. Once bound to a macromolecule such as a protein, the 
intramolecular motions of the peripheral phenyl rings of TPE 
are restricted, and the dye becomes emissive 
23
. In contrast to 
ThT, TPE-TPP does not have any electron donating or accept-
ing groups conjugated to its fluorogenic unit (Figure 1A). 
Therefore, it is unlikely to undergo the twisted intramolecular 
charge transfer mechanism ascribed to ThT fluorescence 
55,56
.  
    Immediate TPE-TPP fluorescence was observed following 
incubation with all the freshly prepared (non-aggregated) pro-
teins used in this study, i.e. α-LA, HEWL, D76N β2m, RCM 
κ-casein, αB-crystallin and α-synuclein. However, no further 
enhancement of TPE-TPP fluorescence occurred when the 
proteins were induced to form the molten globule state or 
amorphous aggregates. In contrast, TPE-TPP exhibited signif-
icant fluorescence enhancement when incubated with proteins 
as they underwent fibril formation. TPE-TPP is like ThT in 
binding preferentially to the cross β-sheet structure that is 
characteristic of amyloid fibrils. The exact mechanism of ThT 
interaction with amyloid fibrils is a matter of debate. Potential-
ly, TPE-TPP could interact with hydrophobic residues and 
emit fluorescence. Molten globule states and amorphous ag-
gregates both have significant exposed hydrophobicity but 
they do not have well-defined β-sheet conformations in place 
and are much more dynamic and less-structured entities than 
the highly structured amyloid fibrils and hence do not provide 
significant physical constraint to enhance TPE-TPP fluores-
cence. Thus, TPE-TPP is a fluorescent dye that selectively 
monitors in vitro amyloid fibril formation, but not molten 
globule states or amorphous (disordered) protein aggregates. 
Following incubation, TPE-TPP exhibited in situ and ex situ 
fluorescence enhancement much earlier than ThT during pro-
tein fibril formation, suggesting that TPE-TPP can interact 
with prefibrillar aggregates but not interfere with aggregate 
formation. Furthermore, a significant blue shift in the fluores-
cence emission spectrum of TPE-TPP occurred in the presence 
of prefibrillar, oligomeric species compared to native forms of 
the same protein (Figures 3A and S3). The blue shift observed 
in the fluorescence emission spectrum when TPE-TPP inter-
acted with prefibrillar protein species also occurs for TPE-TPP 
in the most viscous solvent, glycerol, when compared with 
less viscous solvents or solvents with greater polarity, and is 
accompanied by an increase in fluorescence intensity at the 
wavelength emission maximum (Figures S6 and S7). For ex-
ample, the emission maximum of TPE-TPP is ~470 nm in 
ethylene glycol but is shifted to ~430 nm in 25% v/v glycerol 
and is enhanced in intensity (Figure S6). Only a small change 
in Stokes shift is observed when the glycerol percentage is 
increased from 25% to 100% v/v but a large and linear in-
crease in fluorescence intensity occurs (Figures S6 and S7). 
Such a viscous and rigid local environment could restrict the 
 
Figure 6. Protein fibril formation monitored by FP. Time-dependent change in FP (∆mP) of TPE-TPP (20 µM) during amyloid fibril formation of (A) 






























intramolecular motions of the excited species and may enable 
the transition of the excited species from a higher energy level 
to the ground state, resulting in a blue shift of the fluorescence 
spectrum. By extrapolation, potentially these observations 
imply that the presence of soluble oligomeric assemblies en-
hances the local viscosity in the surrounding environment of 
the TPE-TPP dye. This is consistent with literature reports that 
the formation of early-stage soluble oligomeric assemblies 




A red shift in TPE-TPP emission upon binding to RCM α-
LA mature fibrils also occurred, which was not observed with 
D76N β2m fibrils (Figure 3A and S3), suggesting that TPE-
TPP can also detect morphological variations in amyloid fi-
brils. When the dye molecules bind to the mature fibrils of 
ordered structure, they may have to adjust their conformation, 
for example via rearranging the dihedral angle between the 
phenyl rings and the central double bond of TPE, to fit into the 
binding site. As a result, a red shift in the spectrum would be 
observer.  
TPE-TPP can thus recognise and bind to various protein 
forms with different specificity resulting in spectral changes. 
Importantly, by monitoring such changes in the TPE-TPP 
emission spectrum, it is feasible to differentiate between non-
aggregated, pre- and fibrillar protein forms. Although com-
plementary assays based on TEM or atomic force microscopy 
are always useful to characterize protein morphology, the pos-
sibilities of using TPE-TPP fluorescence provides a rapid and 
convenient way to differentiate proteins adopting different 
morphologies.  
CONCLUSIONS 
In summary, our work demonstrates that TPE-TPP has many 
advantages over ThT in its applicability to monitor amyloid 
fibril formation. TPE-TPP detects the emergence of prefibril-
lar aggregates, is more robust in monitoring amyloid fibril 
formation at highly acidic pH and/or high temperatures, and it 
can be used in the presence of exogenous potential inhibitors, 
including in high-throughput screening. It also does not un-
dergo self-quenching when present in excess compared to the 
concentration of the fibrils, and retains its fluorescence proper-
ties when used with aged amyloid fibrils. Furthermore, TPE-
TPP fluorescence can monitor the oligomeric pathway of a 
protein during amyloid fibril formation. Thus, we propose that 
in many respects, TPE-TPP is a superior dye for fluorescence-
based detection and characterization of amyloid fibril aggrega-
tion. 
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